Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1291579
PUBLISHER: IMARC | PRODUCT CODE: 1291579
Antacids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global antacids market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.
Antacids are over-the-counter (OTC) medications that neutralize the acid in the stomach to relieve indigestion and heartburn. They contain ingredients such as sodium bicarbonate, aluminum, magnesium hydroxide, and calcium and are commonly available in convenient chewable tablets, powder, and liquid forms. Antacids are widely used for treating sore stomach, dyspepsia discomfort, stomach ulcers, inflammation, acid indigestion, and stomach upset. Acid neutralizers, promotility agents, and proton pump inhibitors are common drugs that weaken the acid in the stomach. They assist in protecting the stomach lining from the duodenum, esophagus, and harsh acids released while eating. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.
Antacids Market Trends:
The increasing prevalence of gastroesophageal reflux diseases (GERD) is one of the key factors driving the growth of the market. Antacids are widely used as they are cost-effective and assist in relieving inflammation, swelling, pain, and irritation associated with heartburn. In line with this, changing lifestyles, such as irregular dietary habits, sleep patterns, and sedentary lifestyles, is positively impacting the market growth. Moreover, various product innovations, such as the development of raft-forming antacids that are safe and strong medications that provide higher efficacy and increased duration of action, are providing an impetus to the market growth. Additionally, the widespread adoption of chewable tables in different flavors that are easy to store, provide the correct amount of dosage, and improve patient adherence is favoring the market growth. Other factors, such as the rising geriatric population that are prone to acidic complications, easy product availability through e-commerce platforms, and the increasing prevalence of heartburn among the masses, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antacids market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, formulation type and distribution channel.
Breakup by Drug Class:
Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
Breakup by Formulation Type:
Tablet
Liquid
Powder
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
- How has the global antacids market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global antacids market?
- What are the key regional markets?
- What is the breakup of the market based on the drug class?
- What is the breakup of the market based on the formulation type?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global antacids market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A5082
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Antacids Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 Proton Pump Inhibitors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 H2 Antagonist
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Acid Neutralizers
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Pro-Motility Agents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Formulation Type
- 7.1 Tablet
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Liquid
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Powder
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 AstraZeneca plc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Bayer AG
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Boehringer Ingelheim International GmbH
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Dr. Reddy's Laboratories Ltd.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 GlaxoSmithKline plc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Johnson & Johnson
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Procter & Gamble Company
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Reckitt Benckiser Group PLC
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Sanofi S.A.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Sun Pharmaceutical Industries Ltd.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Takeda Pharmaceutical Company Limited
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
Product Code: SR112023A5082
List of Figures
- Figure 1: Global: Antacids Market: Major Drivers and Challenges
- Figure 2: Global: Antacids Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2022
- Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2022
- Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2022
- Figure 7: Global: Antacids Market: Breakup by Region (in %), 2022
- Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: North America: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: North America: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: United States: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: United States: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Canada: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: China: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: China: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Japan: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: India: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: India: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: South Korea: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Australia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Indonesia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Europe: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Germany: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: France: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: France: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: United Kingdom: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Italy: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Spain: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Russia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Latin America: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Brazil: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Mexico: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2022
- Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Global: Antacids Industry: SWOT Analysis
- Figure 80: Global: Antacids Industry: Value Chain Analysis
- Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Antacids Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
- Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million US$), 2023-2028
- Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Antacids Market: Competitive Structure
- Table 7: Global: Antacids Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.